Stephen Willey
Stock Analyst at Stifel
(3.82)
# 683
Out of 5,057 analysts
124
Total ratings
41.76%
Success rate
12.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTX Nkarta | Maintains: Buy | $12 → $11 | $1.93 | +471.43% | 5 | Nov 11, 2025 | |
| IRON Disc Medicine | Reinstates: Buy | $125 | $84.25 | +48.38% | 1 | Nov 3, 2025 | |
| ACLX Arcellx | Reinstates: Buy | $129 | $88.94 | +45.04% | 1 | Oct 16, 2025 | |
| INCY Incyte | Maintains: Buy | $110 → $115 | $106.88 | +7.60% | 7 | Sep 22, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $30 → $9 | $3.82 | +135.91% | 3 | Aug 29, 2025 | |
| INSM Insmed | Maintains: Buy | $121 → $145 | $193.10 | -24.91% | 8 | Aug 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $8 → $7 | $3.72 | +88.43% | 7 | Aug 8, 2025 | |
| EXEL Exelixis | Maintains: Hold | $38 → $41 | $43.02 | -4.70% | 19 | Jul 29, 2025 | |
| CELC Celcuity | Reinstates: Buy | $30 | $85.99 | -65.11% | 1 | Jul 1, 2025 | |
| CBIO Crescent Biopharma | Initiates: Buy | $28 | $13.08 | +114.15% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $5 | $1.56 | +220.51% | 4 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $20 | $4.91 | +307.33% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $35 | $12.51 | +179.78% | 5 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $100 | $9.91 | +909.08% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.19 | +237.55% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $28 | $18.64 | +50.21% | 6 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $14.35 | +227.53% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.65 | +518.72% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.69 | +136.69% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $39.70 | +56.17% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $4.81 | +87.30% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.57 | +664.33% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $1.98 | +14,482.28% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $2.61 | +704.60% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $1.45 | +175.86% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $449.05 | -72.61% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $69.45 | -32.33% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $55.10 | +97.82% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $22.44 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $7.70 | +198.70% | 5 | Feb 7, 2018 |
Nkarta
Nov 11, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $1.93
Upside: +471.43%
Disc Medicine
Nov 3, 2025
Reinstates: Buy
Price Target: $125
Current: $84.25
Upside: +48.38%
Arcellx
Oct 16, 2025
Reinstates: Buy
Price Target: $129
Current: $88.94
Upside: +45.04%
Incyte
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $115
Current: $106.88
Upside: +7.60%
X4 Pharmaceuticals
Aug 29, 2025
Maintains: Buy
Price Target: $30 → $9
Current: $3.82
Upside: +135.91%
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $121 → $145
Current: $193.10
Upside: -24.91%
AbCellera Biologics
Aug 8, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.72
Upside: +88.43%
Exelixis
Jul 29, 2025
Maintains: Hold
Price Target: $38 → $41
Current: $43.02
Upside: -4.70%
Celcuity
Jul 1, 2025
Reinstates: Buy
Price Target: $30
Current: $85.99
Upside: -65.11%
Crescent Biopharma
Jun 25, 2025
Initiates: Buy
Price Target: $28
Current: $13.08
Upside: +114.15%
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.56
Upside: +220.51%
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $4.91
Upside: +307.33%
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $12.51
Upside: +179.78%
Mar 21, 2025
Maintains: Buy
Price Target: $240 → $100
Current: $9.91
Upside: +909.08%
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.19
Upside: +237.55%
Oct 28, 2024
Maintains: Buy
Price Target: $21 → $28
Current: $18.64
Upside: +50.21%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $14.35
Upside: +227.53%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.65
Upside: +518.72%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.69
Upside: +136.69%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $39.70
Upside: +56.17%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $4.81
Upside: +87.30%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.57
Upside: +664.33%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $1.98
Upside: +14,482.28%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $2.61
Upside: +704.60%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $1.45
Upside: +175.86%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $449.05
Upside: -72.61%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $69.45
Upside: -32.33%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $55.10
Upside: +97.82%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $22.44
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $7.70
Upside: +198.70%